PortfoliosLab logoPortfoliosLab logo
INO vs. QTEX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INO vs. QTEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inovio Pharmaceuticals, Inc. (INO) and QTREX Quantum Ltd. (QTEX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INO achieves a -34.48% return, which is significantly lower than QTEX's 157.78% return.


INO

1D
-5.79%
1M
-0.00%
YTD
-34.48%
6M
-43.56%
1Y
-46.23%
3Y*
-45.25%
5Y*
-58.74%
10Y*
-37.87%

QTEX

1D
-24.68%
1M
395.73%
YTD
157.78%
6M
101.74%
1Y
272.39%
3Y*
18.62%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

INO vs. QTEX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
INO
Inovio Pharmaceuticals, Inc.
-34.48%-4.92%-70.10%-67.31%-68.74%-36.59%
QTEX
QTREX Quantum Ltd.
157.78%-11.76%-3.77%-17.83%-68.99%-12.42%

Correlation

The correlation between INO and QTEX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jul 15, 2021

0.17

Fundamentals

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INO vs. QTEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INO
INO Risk / Return Rank: 1919
Overall Rank
INO Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
INO Sortino Ratio Rank: 2424
Sortino Ratio Rank
INO Omega Ratio Rank: 2323
Omega Ratio Rank
INO Calmar Ratio Rank: 1414
Calmar Ratio Rank
INO Martin Ratio Rank: 1313
Martin Ratio Rank

QTEX
QTEX Risk / Return Rank: 8686
Overall Rank
QTEX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
QTEX Sortino Ratio Rank: 9696
Sortino Ratio Rank
QTEX Omega Ratio Rank: 9393
Omega Ratio Rank
QTEX Calmar Ratio Rank: 8484
Calmar Ratio Rank
QTEX Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INO vs. QTEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and QTREX Quantum Ltd. (QTEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INOQTEXDifference

Sharpe ratio

Return per unit of total volatility

-0.53

1.30

-1.82

Sortino ratio

Return per unit of downside risk

-0.27

4.36

-4.63

Omega ratio

Gain probability vs. loss probability

0.96

1.52

-0.56

Calmar ratio

Return relative to maximum drawdown

-0.73

3.49

-4.22

Martin ratio

Return relative to average drawdown

-1.25

6.49

-7.74

INO vs. QTEX - Sharpe Ratio Comparison

The current INO Sharpe Ratio is -0.53, which is lower than the QTEX Sharpe Ratio of 1.30. The chart below compares the historical Sharpe Ratios of INO and QTEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INOQTEXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.53

1.30

-1.82

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.68

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.41

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.18

-0.07

-0.11

Drawdowns

INO vs. QTEX - Drawdown Comparison

The maximum INO drawdown since its inception was -99.95%, roughly equal to the maximum QTEX drawdown of -96.84%. Use the drawdown chart below to compare losses from any high point for INO and QTEX.


Loading charts...

Drawdown Indicators


INOQTEXDifference

Max Drawdown

Largest peak-to-trough decline

-99.95%

-96.84%

-3.11%

Max Drawdown (1Y)

Largest decline over 1 year

-63.41%

-80.33%

+16.92%

Max Drawdown (3Y)

Largest decline over 3 years

-92.44%

-86.94%

-5.50%

Max Drawdown (5Y)

Largest decline over 5 years

-99.13%

Max Drawdown (10Y)

Largest decline over 10 years

-99.72%

Current Drawdown

Current decline from peak

-99.95%

-75.81%

-24.14%

Average Drawdown

Average peak-to-trough decline

-92.35%

-81.96%

-10.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.06%

43.15%

-6.09%

Volatility

INO vs. QTEX - Volatility Comparison

The current volatility for Inovio Pharmaceuticals, Inc. (INO) is 23.06%, while QTREX Quantum Ltd. (QTEX) has a volatility of 129.04%. This indicates that INO experiences smaller price fluctuations and is considered to be less risky than QTEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INOQTEXDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.06%

129.04%

-105.98%

Volatility (6M)

Calculated over the trailing 6-month period

66.11%

142.62%

-76.51%

Volatility (1Y)

Calculated over the trailing 1-year period

88.27%

211.24%

-122.97%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

86.08%

195.29%

-109.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.38%

195.29%

-101.91%

Dividends

INO vs. QTEX - Dividend Comparison

Neither INO nor QTEX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INO vs. QTEX - Financials Comparison

This section allows you to compare key financial metrics between Inovio Pharmaceuticals, Inc. and QTREX Quantum Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00M10.00M202220232024202520260
(INO) Total Revenue
(QTEX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


INO and QTEX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QTEX has higher volatility (129.04%) compared to INO (23.06%). In terms of maximum drawdown, INO dropped -99.95% vs QTEX's -96.84%.

QTEX currently has the higher Sharpe Ratio (1.30 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INO and QTEX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer